Skip to content
Resources > Reports

State of Market Intelligence: Market Maturity Index Report

Today’s markets move at breakneck speed—generating massive amounts of information. Add in an unprecedented level of volatility and an overall increase in the pace of business, to put it lightly: gathering and acting on market intelligence has never been more challenging.

And while the pace of business has accelerated, organizations largely operate in a world full of slow decision-making. Intelligence that powers strategic decisions requires knowledge workers to be agile.

When it comes to tactically employing a sophisticated market intelligence practice, it is important to level-set and know where your company is in terms of market intelligence maturity. It is a matter of understanding where you stand without simply reacting to your competitors.

Enter: the market intelligence maturity index.

In this report, based around data from our State of Generative AI and Market Intelligence 2023survey, we delve into the challenges and costs associated with not solving them, and outline the three stages of market intelligence maturity (or lack thereof).

Explore more

APAC Macro Briefing 2026: Risk Meets Opportunity

In this report, we show how resources and workflows available in the AlphaSense platform can help contextualize the APAC macro environment, exploring the key implications for corporate leaders and investors across sectors.
Title slide for "APAC Macro Briefing 2026: Risk Meets Opportunity" with a map of the Asia-Pacific region.

Top AI Use Cases for Private Equity

In this report, discover how private equity teams are leveraging AI to accelerate conviction with speed. With purpose built, AI-driven solutions like AlphaSense, teams are gaining a competitive advantage with custom workflows and unmatched content sets for the most differentiated deal intelligence.
Top AI Use Cases For Private Equity by Barb Tague, Financial Research Leader. Illustration featuring isometric buildings and currency symbols.

AI in Drug Development 2026: From Experimentation to Execution

Learn how AI is reshaping drug development in real time, turning AI execution into a key competitive differentiator.
Presentation slide titled "AI in Drug Development 2026: From Experimentation to Execution" by Sara Mallatt and Sean Carmichael, with line art of laboratory equipment.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.